C. Joly et al., MOLECULAR, FUNCTIONAL, AND PHARMACOLOGICAL CHARACTERIZATION OF THE METABOTROPIC GLUTAMATE-RECEPTOR TYPE-5 SPLICE VARIANTS - COMPARISON WITHMGLUR1, The Journal of neuroscience, 15(5), 1995, pp. 3970-3981
The main excitatory neurotransmitter in the brain, glutamate (Glu), ac
tivates not only receptor-channels, but also receptors coupled to G-pr
otein called metabotropic Glu receptors (mGluRs), Eight genes coding f
or mGluRs have been characterized to date giving rise to even more pro
teins due to alternative splicing phenomena, Here we characterized a s
plice variant of mGluR5, called mGluR5b which contains a 32 amino acid
fragment inserted in the cytoplasmic tail, 50 residues after the 7th
transmembrane domain. mGluR5b mRNAs are present in different regions o
f the adult rat brain and are expressed at a higher level than mGluR5a
mRNA, functional analysis of mGluR5a and mGluR5b revealed that they s
hare all the properties of mGluR1a, but not those of mGluR1b or 1c. Li
ke mGluR1a, both mGluR5a and mGluR5b activate a rapid and transient cu
rrent in Xenopus oocytes. When expressed in LLC-PK1 cells, they show t
he same subcellular distribution as mGluR1a, and stimulate both inosit
ol phosphate (IP) and cAMP production. Moreover, cells expressing mGlu
R5a or mGluR5b, like those expressing mGluR1a have a higher basal PLC
activity that is not inhibited by glutamate-pyruvate transaminase (GPT
), suggesting that these receptors have an intrinsic activity. Interes
tingly, the pharmacological profiles of mGluR5a and b are identical, b
ut different from that of mGluR1a, Most agonists, except glutamate, ar
e more potent on mGluR5a/b than on mGluR1a, Interestingly, the mGluR1a
antagonists MCPG and 4CPG have no effect on mGluR5a/b; 4C3HPG which i
s a full antagonist at mGluR1a is a partial agonist at mGluR5a/b. Thes
e results indicate that the long C-terminal intracellular domain prese
nt only in mGluR1a and mGluR5a/b, although not well conserved, is like
ly to be involved in the specific functional properties of these recep
tors. Although the ligand recognition sites of mGluR5a/b and mGluR1a a
re highly conserved, these receptors have different pharmacology.